|

Nebivolol Clinical Trials

1 actively recruiting trial across 1 location

Also known as: Bystolic

Pipeline

Phase 2/3: 1

Top Sponsors

  • Stanford University1

Indications

  • Myocardial Bridge of Coronary Artery1
  • Microvascular Angina1
  • Vasospastic Angina1
  • Angina Pectoris1
  • Heart Disease1

Palo Alto, California1 trial

Efficacy of Targeted Medical Therapy in Angina and Nonobstructive Coronary Arteries

Stanford Hospital

Phase 2/3

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.